339 related articles for article (PubMed ID: 21078888)
1. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.
Zhu S; Pan W; Shi P; Gao H; Zhao F; Song X; Liu Y; Zhao L; Li X; Shi Y; Qian Y
J Exp Med; 2010 Nov; 207(12):2647-62. PubMed ID: 21078888
[TBL] [Abstract][Full Text] [Related]
2. TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation.
Qu F; Gao H; Zhu S; Shi P; Zhang Y; Liu Y; Jallal B; Yao Y; Shi Y; Qian Y
Mol Cell Biol; 2012 Oct; 32(19):3925-37. PubMed ID: 22851696
[TBL] [Abstract][Full Text] [Related]
3. NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3.
Ma C; Lin W; Liu Z; Tang W; Gautam R; Li H; Qian Y; Huang H; Wang X
EMBO Rep; 2017 Apr; 18(4):586-602. PubMed ID: 28219902
[TBL] [Abstract][Full Text] [Related]
4. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li X
Cytokine; 2008 Feb; 41(2):105-13. PubMed ID: 18061473
[TBL] [Abstract][Full Text] [Related]
5. RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling.
Lin W; Wang N; Zhou K; Su F; Jiang Y; Shou J; Liu H; Ma C; Qian Y; Wang K; Wang X
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29674348
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor Receptor Associated Factor 3 Modulates Cartilage Degradation through Suppression of Interleukin 17 Signaling.
Hu G; Zhang N; Li J; Wang J; Wu W; Li J; Tong W; Zhao X; Dai L; Zhang X
Am J Pathol; 2020 Aug; 190(8):1701-1712. PubMed ID: 32416098
[TBL] [Abstract][Full Text] [Related]
7. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
[TBL] [Abstract][Full Text] [Related]
8. IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination.
Kang Z; Liu L; Spangler R; Spear C; Wang C; Gulen MF; Veenstra M; Ouyang W; Ransohoff RM; Li X
J Neurosci; 2012 Jun; 32(24):8284-92. PubMed ID: 22699909
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells.
Liu G; Guo J; Liu J; Wang Z; Liang D
Clin Immunol; 2014 Oct; 154(2):127-40. PubMed ID: 25076485
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6.
Rong Z; Cheng L; Ren Y; Li Z; Li Y; Li X; Li H; Fu XY; Chang Z
Cell Signal; 2007 Jul; 19(7):1514-20. PubMed ID: 17346928
[TBL] [Abstract][Full Text] [Related]
11. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6.
Hartupee J; Liu C; Novotny M; Sun D; Li X; Hamilton TA
J Immunol; 2009 Feb; 182(3):1660-6. PubMed ID: 19155515
[TBL] [Abstract][Full Text] [Related]
12. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.
Qian Y; Liu C; Hartupee J; Altuntas CZ; Gulen MF; Jane-Wit D; Xiao J; Lu Y; Giltiay N; Liu J; Kordula T; Zhang QW; Vallance B; Swaidani S; Aronica M; Tuohy VK; Hamilton T; Li X
Nat Immunol; 2007 Mar; 8(3):247-56. PubMed ID: 17277779
[TBL] [Abstract][Full Text] [Related]
13. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
14. SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.
Onishi RM; Park SJ; Hanel W; Ho AW; Maitra A; Gaffen SL
J Biol Chem; 2010 Oct; 285(43):32751-32759. PubMed ID: 20729198
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2.
Li H; Wang N; Jiang Y; Wang H; Xin Z; An H; Pan H; Ma W; Zhang T; Wang X; Lin W
EMBO Rep; 2022 Nov; 23(11):e54603. PubMed ID: 36161689
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes.
Zepp JA; Liu C; Qian W; Wu L; Gulen MF; Kang Z; Li X
J Immunol; 2012 Jul; 189(1):33-7. PubMed ID: 22649194
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.
Lin YC; Huang DY; Chu CL; Lin YL; Lin WW
Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes.
Xie P; Poovassery J; Stunz LL; Smith SM; Schultz ML; Carlin LE; Bishop GA
J Leukoc Biol; 2011 Dec; 90(6):1149-57. PubMed ID: 21971520
[TBL] [Abstract][Full Text] [Related]
19. TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor-mediated inflammatory responses.
Miyashita Y; Kouwaki T; Tsukamoto H; Okamoto M; Nakamura K; Oshiumi H
Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34819358
[TBL] [Abstract][Full Text] [Related]
20. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction.
Schwandner R; Yamaguchi K; Cao Z
J Exp Med; 2000 Apr; 191(7):1233-40. PubMed ID: 10748240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
